{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:26:46Z","timestamp":1776821206578,"version":"3.51.2"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T00:00:00Z","timestamp":1517788800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00079","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T09:54:42Z","timestamp":1517824482000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection"],"prefix":"10.3389","volume":"9","author":[{"given":"Ulrike","family":"Schleicher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Liese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Justies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mischke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Haeberlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Sebald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Kalinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Bogdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8219","DOI":"10.1128\/JVI.78.15.8219-8228.2004","article-title":"Characterization of the murine alpha interferon gene family","volume":"78","author":"van Pesch","year":"2004","journal-title":"J Virol"},{"key":"B2","first-page":"71","article-title":"The receptor of the type I interferon family","volume":"316","author":"Uze","year":"2007","journal-title":"Curr Top Microbiol Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B4","first-page":"73","article-title":"The interferon response circuit in antiviral host defense","volume":"71","author":"Haller","year":"2009","journal-title":"Verh K Acad Geneeskd Belg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.it.2017.05.005","article-title":"Type I interferon in chronic virus infection and cancer","volume":"38","author":"Snell","year":"2017","journal-title":"Trends Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.0105-2896.2004.00207.x","article-title":"The role of type I interferons in non-viral infections","volume":"202","author":"Bogdan","year":"2004","journal-title":"Immunol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nri3133","article-title":"Immunomodulatory functions of type I interferons","volume":"12","author":"Gonzalez-Navajas","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nri3845","article-title":"Type I interferons in anticancer immunity","volume":"15","author":"Zitvogel","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nri1684","article-title":"The yin and yang of type I interferon activity in bacterial infection","volume":"5","author":"Decker","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.4049\/jimmunol.1402794","article-title":"Interfering with immunity: detrimental role of type I IFNs during infection","volume":"194","author":"Stifter","year":"2015","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0960-9822(98)70086-7","article-title":"Interferon-\u03b2 is required for interferon-\u03b1 production in mouse fibroblasts","volume":"8","author":"Erlandsson","year":"1998","journal-title":"Curr Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.immuni.2006.08.009","article-title":"Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors","volume":"25","author":"Honda","year":"2006","journal-title":"Immunity"},{"key":"B14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1084\/jem.20011666","article-title":"Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo","volume":"195","author":"Barchet","year":"2002","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1084\/jem.20061293","article-title":"NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs","volume":"204","author":"Schleicher","year":"2007","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"i60","DOI":"10.1136\/annrheumdis-2011-200596","article-title":"Leishmaniasis in rheumatology, hematology, and oncology: epidemiological, immunological, and clinical aspects and caveats","volume":"71","author":"Bogdan","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/1521-4141(2000)30:8<2257::AID-IMMU2257>3.0.CO;2-U","article-title":"Regulation of type 2 NO synthase by type I interferons in macrophages infected with Leishmania major","volume":"30","author":"Mattner","year":"2000","journal-title":"Eur J Immunol"},{"key":"B20","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.4049\/jimmunol.136.8.3062","article-title":"The enhancing effect of interferon-\u03b2 and -\u03b3 on the killing of Leishmania tropica major in human mononuclear phagocytes in vitro","volume":"136","author":"Passwell","year":"1986","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1074-7613(00)80460-4","article-title":"Type 1 interferon (IFN-\u03b1\/\u03b2) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite","volume":"8","author":"Diefenbach","year":"1998","journal-title":"Immunity"},{"key":"B22","doi-asserted-by":"publisher","first-page":"7574","DOI":"10.4049\/jimmunol.172.12.7574","article-title":"Protection against progressive leishmaniasis by IFN-\u03b2","volume":"172","author":"Mattner","year":"2004","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.160.8.3627","article-title":"Cutting Edge: CpG oligodesoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis","volume":"160","author":"Zimmermann","year":"1998","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.4049\/jimmunol.0802860","article-title":"IFN-beta impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis","volume":"182","author":"Khouri","year":"2009","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.4049\/jimmunol.0903273","article-title":"Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites","volume":"184","author":"Xin","year":"2010","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1073\/pnas.1621447114","article-title":"Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis","volume":"114","author":"Rossi","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"M\u00fcller","year":"1994","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1084\/jem.20040976","article-title":"Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes","volume":"200","author":"Auerbuch","year":"2004","journal-title":"J Exp Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0167-5699(97)01126-2","article-title":"Speed congenics: a classic technique in the fast lane (relatively speaking)","volume":"18","author":"Wakeland","year":"1997","journal-title":"Immunol Today"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/eji.1830260722","article-title":"Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response","volume":"26","author":"Mattner","year":"1996","journal-title":"Eur J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1084\/jem.191.12.2121","article-title":"Fibroblasts as host cells in latent leishmaniosis","volume":"191","author":"Bogdan","year":"2000","journal-title":"J Exp Med"},{"key":"B32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4049\/jimmunol.137.2.702","article-title":"Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB\/c mice","volume":"137","author":"Solbach","year":"1986","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/eji.200323825","article-title":"Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase","volume":"33","author":"Blos","year":"2003","journal-title":"Eur J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0035-9203(91)90226-O","article-title":"Human urine stimulates growth of Leishmania in vitro","volume":"85","author":"Howard","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0169-4758(96)40010-2","article-title":"A simple method for quantifying Leishmania in tissues of infected animals","volume":"13","author":"Lima","year":"1997","journal-title":"Parasitol Today"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1084\/jem.183.4.1501","article-title":"Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase","volume":"183","author":"Stenger","year":"1996","journal-title":"J Exp Med"},{"key":"B37","first-page":"109","article-title":"Limiting dilution assays for the separation, characterization and quantification of biologically active particles and their clonal progeny","volume-title":"Cell Separation: Methods and Selected Applications","author":"Taswell","year":"1986"},{"key":"B38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J Immunol Methods"},{"key":"B39","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1084\/jem.20020045","article-title":"The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte\/macrophage colony-stimulating factor","volume":"195","author":"Gilliet","year":"2002","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0952-7915(01)00305-3","article-title":"The interferon-alpha\/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors","volume":"14","author":"Taniguchi","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/intimm\/dxh318","article-title":"Regulation of the type I IFN induction: a current view","volume":"17","author":"Honda","year":"2005","journal-title":"Int Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1084\/jem.181.3.961","article-title":"Mice from genetically resistant background lacking the interferon-\u03b3 receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response","volume":"181","author":"Swihart","year":"1995","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1084\/jem.189.3.521","article-title":"Type I interferons keep activated T cells alive","volume":"189","author":"Marrack","year":"1999","journal-title":"J Exp Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<1041::AID-IMMU1041>3.0.CO;2-#","article-title":"Interferon-\u03b2 mediates stromal cell rescue of T cells from apoptosis","volume":"29","author":"Pilling","year":"1999","journal-title":"Eur J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1126\/science.272.5270.1947","article-title":"Induction of bystander T cell proliferation by viruses and type I interferon in vivo","volume":"272","author":"Tough","year":"1996","journal-title":"Science"},{"key":"B46","first-page":"126","article-title":"Experimental cutaneous leishmaniasis V. Protective immunity in subclinical and self-healing infection in the mouse","volume":"23","author":"Preston","year":"1976","journal-title":"Clin Exp Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1126\/science.1636090","article-title":"Establishment of stable, cell-mediated immunity that makes \u201csusceptible\u201d mice resistant to Leishmania major","volume":"257","author":"Bretscher","year":"1992","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1084\/jem.20041964","article-title":"A type I interferon autocrine-paracrine loop is involved in toll-like receptor-induced interleukin-12p70 secretion by dendritic cells","volume":"201","author":"Gautier","year":"2005","journal-title":"J Exp Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1002\/eji.200737182","article-title":"TLR9 signalling is essential for the innate NK cell response in murine cutaneous leishmaniasis","volume":"37","author":"Liese","year":"2007","journal-title":"Eur J Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<687::AID-IMMU687>3.0.CO;2-N","article-title":"Dendritic cells, but not macrophages produce IL-12 immediately following Leishmania donovani infection","volume":"28","author":"Gorak","year":"1998","journal-title":"Eur J Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/eji.200324391","article-title":"Two waves of antigen-containing dendritic cells in vivo in experimental Leishmania major infection","volume":"34","author":"Misslitz","year":"2004","journal-title":"Eur J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.4049\/jimmunol.180.7.4355","article-title":"Modulation of dendritic cell function by Leishmania parasites","volume":"180","author":"Soong","year":"2008","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/eji.1830200528","article-title":"Tumor necrosis factor-\u03b1 in combination with interferon-\u03b3, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes","volume":"20","author":"Bogdan","year":"1990","journal-title":"Eur J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.179.4.1367","article-title":"CD4+ effector cells default to the Th2 pathway in interferon-\u03b3-deficient mice infected with Leishmania major","volume":"179","author":"Wang","year":"1994","journal-title":"J Exp Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.4049\/jimmunol.166.6.4012","article-title":"Rapidly fatal leishmaniasis in resistant C57BL\/6 mice lacking tumor necrosis factor","volume":"166","author":"Wilhelm","year":"2001","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"877","DOI":"10.4049\/jimmunol.0902346","article-title":"Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivo","volume":"184","author":"Lykens","year":"2010","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/ni910","article-title":"Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock","volume":"4","author":"Karaghiosoff","year":"2003","journal-title":"Nat Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20040769","article-title":"Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection","volume":"200","author":"Carrero","year":"2004","journal-title":"J Exp Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1084\/jem.20040712","article-title":"Type I interferon production enhances susceptibility to Listeria monocytogenes infection","volume":"200","author":"O\u2019Connell","year":"2004","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1089\/jir.2005.25.694","article-title":"Hypervirulent M. tuberculosis W\/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway","volume":"25","author":"Manca","year":"2005","journal-title":"J Interferon Cytokine Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.4049\/jimmunol.177.5.3193","article-title":"Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection","volume":"177","author":"Costa","year":"2006","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"7059","DOI":"10.4049\/jimmunol.177.10.7059","article-title":"TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi","volume":"177","author":"Koga","year":"2006","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.4049\/jimmunol.178.5.3143","article-title":"The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis","volume":"178","author":"Stanley","year":"2007","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"566","DOI":"10.4049\/jimmunol.181.1.566","article-title":"IFN-alpha\/beta signaling is required for polarization of cytokine responses toward a protective type 1 pattern during experimental cryptococcosis","volume":"181","author":"Biondo","year":"2008","journal-title":"J Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.4049\/jimmunol.178.5.3126","article-title":"Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria","volume":"178","author":"Mancuso","year":"2007","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2353\/ajpath.2008.070591","article-title":"Lymphadenopathy in a novel mouse model of Bartonella-induced cat scratch disease results from lymphocyte immigration and proliferation and is regulated by interferon-alpha\/beta","volume":"172","author":"Kunz","year":"2008","journal-title":"Am J Pathol"},{"key":"B67","first-page":"1931","article-title":"Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A","volume":"119","author":"Martin","year":"2009","journal-title":"J Clin Invest"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.2353\/ajpath.2010.091158","article-title":"Type-I IFN signaling suppresses an excessive IFN-gamma response and thus prevents lung damage and chronic inflammation during Pneumocystis (PC) clearance in CD4 T cell-competent mice","volume":"176","author":"Meissner","year":"2010","journal-title":"Am J Pathol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1084\/jem.20091746","article-title":"Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma","volume":"207","author":"Rayamajhi","year":"2010","journal-title":"J Exp Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1128\/IAI.01176-10","article-title":"Type I interferons increase host susceptibility to Trypanosoma cruzi infection","volume":"79","author":"Chessler","year":"2011","journal-title":"Infect Immun"},{"key":"B71","doi-asserted-by":"publisher","first-page":"6205","DOI":"10.4049\/jimmunol.1200255","article-title":"Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis","volume":"188","author":"Desvignes","year":"2012","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e1002811","DOI":"10.1371\/journal.ppat.1002811","article-title":"Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections","volume":"8","author":"Majer","year":"2012","journal-title":"PLoS Pathog"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1002\/eji.201343327","article-title":"Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA","volume":"43","author":"Palomo","year":"2013","journal-title":"Eur J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.celrep.2014.03.018","article-title":"Interferon-mediated innate immune responses against malaria parasite liver stages","volume":"7","author":"Miller","year":"2014","journal-title":"Cell Rep"},{"key":"B75","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature13489","article-title":"Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk","volume":"511","author":"Mayer-Barber","year":"2014","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1172\/JCI70698","article-title":"Type I IFN signaling in CD8- DCs impairs Th1-dependent malaria immunity","volume":"124","author":"Haque","year":"2014","journal-title":"J Clin Invest"},{"key":"B77","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.4049\/jimmunol.1600584","article-title":"Type I IFN inhibits alternative macrophage activation during Mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-gamma signaling","volume":"197","author":"Moreira-Teixeira","year":"2016","journal-title":"J Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.celrep.2016.09.015","article-title":"Type I interferons regulate immune responses in humans with blood-stage Plasmodium falciparum infection","volume":"17","author":"Montes de Oca","year":"2016","journal-title":"Cell Rep"},{"key":"B79","doi-asserted-by":"publisher","first-page":"46321","DOI":"10.1074\/jbc.M302554200","article-title":"Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype","volume":"278","author":"van Pesch","year":"2003","journal-title":"J Biol Chem"},{"key":"B80","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cytogfr.2009.07.005","article-title":"The role of differential expression of human interferon \u2013 a genes in antiviral immunity","volume":"20","author":"Genin","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"B81","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.cell.2011.06.048","article-title":"Structural linkage between ligand discrimination and receptor activation by type I interferons","volume":"146","author":"Thomas","year":"2011","journal-title":"Cell"},{"key":"B82","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2015.12.027","article-title":"Alpha and beta type 1 interferon signaling: passage for diverse biologic outcomes","volume":"164","author":"Ng","year":"2016","journal-title":"Cell"},{"key":"B83","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nm.3424","article-title":"Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection","volume":"20","author":"Liehl","year":"2014","journal-title":"Nat Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.4049\/jimmunol.174.9.5462","article-title":"Role of type I IFNs in pulmonary complications of Pneumocystis murina infection","volume":"174","author":"Meissner","year":"2005","journal-title":"J Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.immuni.2011.12.002","article-title":"Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection","volume":"35","author":"Mayer-Barber","year":"2011","journal-title":"Immunity"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1111\/j.1462-5822.2011.01646.x","article-title":"Dissection of a type I interferon pathway in controlling bacterial intracellular infection in mice","volume":"13","author":"Lippmann","year":"2011","journal-title":"Cell Microbiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2012.00069","article-title":"Natural killer cells in experimental and human leishmaniasis","volume":"2","author":"Bogdan","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"B88","first-page":"193","article-title":"Phagocyte effector functions against Leishmania parasites","volume-title":"Protozoans in Macrophages","author":"Bogdan","year":"2007"},{"key":"B89","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.imbio.2007.12.005","article-title":"The innate immune response against Leishmania parasites","volume":"213","author":"Liese","year":"2008","journal-title":"Immunobiology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.4049\/jimmunol.1203230","article-title":"Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction","volume":"192","author":"Favila","year":"2014","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1128\/MCB.00478-09","article-title":"Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling","volume":"29","author":"Liu","year":"2009","journal-title":"Mol Cell Biol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1365-3024.2009.01167.x","article-title":"Type I IFNs promote the early IFN-gamma response and the IL-10 response in Leishmania mexicana infection","volume":"32","author":"Buxbaum","year":"2010","journal-title":"Parasite Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1126\/science.1199326","article-title":"Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis","volume":"331","author":"Ives","year":"2011","journal-title":"Science"},{"key":"B94","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1096\/fj.11-185165","article-title":"Human cutaneous leishmaniasis: interferon-dependent expression of double-stranded RNA-dependent protein kinase (PKR) via TLR2","volume":"25","author":"Vivarini Ade","year":"2011","journal-title":"FASEB J"},{"key":"B95","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4049\/jimmunol.177.1.22","article-title":"Cutting edge: STAT1 and T-bet play distinct roles in determining outcome of visceral leishmaniasis caused by Leishmania donovani","volume":"177","author":"Rosas","year":"2006","journal-title":"J Immunol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1128\/IAI.00633-10","article-title":"Interferon regulatory factor 7 contributes to the control of Leishmania donovani in the mouse liver","volume":"79","author":"Beattie","year":"2011","journal-title":"Infect Immun"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e1001246","DOI":"10.1371\/journal.ppat.1001246","article-title":"Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection","volume":"7","author":"Paun","year":"2011","journal-title":"PLoS Pathog"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00079\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:19:33Z","timestamp":1693516773000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00079\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":97,"alternative-id":["10.3389\/fimmu.2018.00079"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00079","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,5]]},"article-number":"79"}}